Author/Editor     Kalanj, S; Kračun, I; Rosner, H; Ćosović, Č
Title     Regional distribution of brain gangliosides in Alzheimer's disease
Type     članek
Source     Neurol Croat
Vol. and No.     Letnik 40, št. 4
Publication year     1991
Volume     str. 269-81
Language     eng
Abstract     In this study, brain gangliosides of patients with Alzheimer's disease (AD, N=5) were analyzed and compared with control human brains (C, N=3). Gangliosides were analyzed in seven brain regions: crebral cortex (fronatl, parietal, temporal and occipital), hippocampus, basal telencephalon and frontal white matter. The results demonstrated gangliosides to be decreased in the majority of regions analyzed, however, a significant decrease in gangliosides (nmol LBSA/mg proteins or g fresh weight) in frontal cortex and white matter (P less than 0.05) was recorded. When gangliosides were expressed in nmol LBSA/mg DNA (deoxyribonucleic acid), their basal telencephalon, sugesting that high astroglial proliferation might have concealed the real neuronal degeneration. In the ganglioside composition, all human brain regions contained moderately decreased ganglio-series gangliosides (GT1b, GD1b, GD1a, GM1) but a statistically significant decrease was detected in frontal cortex, and white matter (nmol LBSA/g fresh weight) or frontal cortex, temporal cortex and basal telencephalon (nmol LBSA/mg DNA). In addition, frontal and parietal cortex also showed elevated concentration (nmol LBSA/g fresh weight) of simple gangliosides (GM2, GM3, GM4, GD3). A decreased concentration of ganglio-series gangliosides in Alzheimer's disease correlates with degeneration of cortical neurons. However, elevation of simple gangliosides in frontal and parietal cortex may correlate with: (a) an accelerated lysosomal degradation of gangliosides occurring during neuronal death (GM2); (b) astrogliosis (GM3 and GD3); and (c) activation of oligodendrocytes (GM4). The fact that gangliosides are altered in Alzheimer's disease might be important for better understanding of the pathogenesis of the disease
Descriptors     ALZHEIMER'S DISEASE
GANGLIOSIDES
BRAIN CHEMISTRY
CHROMATOGRAPHY, THIN LAYER
ADULT
MIDDLE AGE
AGED